Facebook
Twitter
LinkedIn
ForwardEndometrial Cancer
This online course is a highlight from the 2021 live virtual symposium which was hosted by the Miami Cancer Institute. The symposium brought together a distinguished faculty to focus on the medical management of common and important challenges facing health-care professionals who care for women with cancer.
Learn more about the Womens’ Cancer Symposium here.
Surgical Management of High-risk Endometrial Cancer: Should Sentinel Lymph Node be the Standard
In this course, Dr. Ginger Gardner of Memorial Sloan Kettering Cancer Center examines the benefits of sentinel lymph mapping for endometrial cancer. She discusses the technique and highlights the studies about detection and outcome.
Learning Objective:
- Evaluate the effectiveness of sentinel lymph node resection in the management of high-risk endometrial cancer.
Immunotherapy in Management of Endometrial Cancer
In this course, Dr. Shannon N. Westin of MD Anderson Cancer Center examines the utility of immunotherapy in the manage of endometrial cancer.
Learning Objectives:
- Review existing data to support use of immunotherapy in endometrial cancer.
- Discuss ongoing trials including immunotherapy for the care of women with endometrial cancer.
- Apply relevant testing strategies to guide choice of immunotherapy in endometrial cancer.
- Discuss adverse event management of immunotherapy.
Target Audience
Breast Surgeons, General Surgeons, Reconstructive Surgeons, Obstetricians and Gynecologists, Oncologists, Medical Oncologists, Physiatrist, Radiation Oncologists, Pathologists, Geneticists, Radiologists, General Practitioners, Nurse Practitioners and all other interested healthcare professionals.
SPEAKERS
Ginger J. Gardner, M.D., FACOG
Section, Ovarian Cancer Surgery
Physician Lead, Gynecology Disease Management Team Alliance
Vice Chair of Hospital Operations, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, New York
Shannon N. Westin, M.D., MPH
Associate Professor
Director, Early Drug Development and Phase 1 Trials
Department of Gynecologic Oncology and Reproductive Medicine
UT MD Anderson Cancer Center,
Houston, Texas
SYMPOSIUM DIRECTORS
John P. Diaz, M.D., FACOG
Director of Gynecologic Minimally Invasive Surgery
Baptist Health South Florida
Lead Physician Clinical Research
Gynecologic Oncology Clinical Trials
Miami Cancer Institute
Gladys L. Giron, M.D., FACS
Breast Surgical Oncology
Cancer Liaison Physician
Miami Cancer Institute
Nicholas C. Lambrou, M.D., FACOG
Chief of Gynecologic Oncology, Miami Cancer Institute
Director of Robotic Surgery, Baptist Health South Florida
Associate Professor, Herbert Wertheim College of Medicine
Florida International University
Starr K. Mautner, M.D., FACS
Breast Surgical Oncology
Cancer Liaison Physician
Miami Cancer Institute
Ginger J. Gardner, M.D., FACOG, faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and will not include discussion of off-label or unapproved product usage.
Shannon N. Westin, M.D., MPH, faculty for this educational activity, has indicated that she receives grant/research support from AstraZeneca, Clovis Oncology, Roche/Genentech, GSK/Tesaro, Novartis, Bayer, ArQule, Bio-Path, Cotinga Pharmaceuticals. She is also a consultant for Merck, Pfizer, Eisai, Zentalis, Agenus, and Circulogene and has indicated that the presentation or discussion will include off-label or unapproved product usage.
Symposium Directors
John P. Diaz, M.D., FACOG, has indicated that he is a member of the speakers’ bureau for AstraZeneca and Merck.
Gladys L. Giron, M.D., FACS, has disclosed that her spouse is a consultant for Stryker.
Nicholas C. Lambrou, M.D., FACOG, has indicated that he is a consultant for Intuitive, Ethicon and Johnson & Johnson.
Starr K. Mautner, M.D., FACS, conference director of this educational activity, has no relevant financial relationship to disclose with ineligible companies.*
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
